You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR BRISDELLE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for BRISDELLE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00786188 ↗	Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause	Completed	Noven Therapeutics	Phase 2	2008-11-01	This is an exploratory 8-week, multicenter, double-blind, randomized, placebo-controlled study of Brisdelle (paroxetine mesylate) Capsules 7.5 mgin subjects with moderate to severe postmenopausal vasomotor symptoms (VMS), defined as follows: - Moderate VMS: Sensation of heat with sweating, able to continue activity - Severe VMS: Sensation of heat with sweating, causing cessation of activity
NCT01101841 ↗	24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms	Completed	Noven Therapeutics	Phase 3	2010-03-01	To assess the safety and efficacy of Brisdelle (paroxetine mesylate) Capsules 7.5 mg for treatment of vasomotor symptoms (VMS) associated with menopause
NCT01361308 ↗	Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)	Completed	Noven Therapeutics	Phase 3	2011-05-01	The purpose of this study is to assess the safety & efficacy of Brisdelle (paroxetine mesylate) Capsules 7.5 mg for treatment of vasomotor symptoms (VMS) associated with menopause.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for BRISDELLE

Condition Name

Chart
Table

Condition Name for BRISDELLE
Intervention	Trials
Hot Flashes	3
Postmenopausal Symptoms	2
Breast Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for BRISDELLE
Intervention	Trials
Hot Flashes	3
Breast Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for BRISDELLE

Trials by Country

Map
Table

Trials by Country for BRISDELLE
Location	Trials
United States	54
Taiwan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for BRISDELLE
Location	Trials
Washington	3
Virginia	3
Tennessee	3
Pennsylvania	3
North Carolina	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for BRISDELLE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for BRISDELLE
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	2
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for BRISDELLE
Clinical Trial Phase	Trials
Completed	4
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BRISDELLE

Sponsor Name

Chart
Table

Sponsor Name for BRISDELLE
Sponsor	Trials
Noven Therapeutics	4
Yung Shin Pharm. Ind. Co., Ltd.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for BRISDELLE
Sponsor	Trials
Industry	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.